Investigators conducted a retrospective cohort study trend analysis of cannabis-related ED visits of older adults from all nonfederal acute care hospitals in California using data from the US Department of Health Care Access and Information.
Seena Fazel of the University of Oxford, UK, and colleagues at the Karolinska Institute in Sweden compared the medicated and non-medicated periods of over 1.4 million beta blocker users.
Exxua (previously named Travivo) is a novel oral serotonin 1A receptor agonist.
The approval was based on data from adequate and well-controlled studies with risperidone long-acting injection (intramuscular).
Patients with acute appendicitis between 2000 and 2020 were evaluated for complications on the basis of having a mental health diagnosis.
The sNDA is supported by data from two phase 3 studies that evaluated the efficacy and safety of brexpiprazole in patients with agitation associated with Alzheimer dementia.
The MAPP2 study included 104 patients who received either MDMA or placebo plus psychotherapy.
The study included approximately 400 adults with a history of bipolar I disorder who had a current episode of mania.
The approval was based on data from 2 trials in adults who met DSM-IV-TR or DSM-5 criteria for MDD and had an inadequate response to 1 to 3 courses of prior antidepressant therapy.
The designation is supported by data from 3 clinical studies.
